We are live on ! Find out more
AFCM

Applied Finance Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 33.63%
This Fund
S&P 500
This Quarter Est. Return
-0.94%
1 Year Est. Return
+33.63%
3 Year Est. Return
+90.36%
5 Year Est. Return
10 Year Est. Return
AUM
$2.3B
AUM Growth
-$40.6M
Cap. Flow
+$27.3M
Cap. Flow %
1.19%
Top 10 Hldgs %
28.3%
Holding
335
New
37
Increased
65
Reduced
82
Closed
38

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$42.6M
2
HST icon
Host Hotels & Resorts
HST
+$37.3M
3
IBM icon
IBM
IBM
+$11.8M
4
DHI icon
D.R. Horton
DHI
+$8.96M
5
FISV
Fiserv Inc
FISV
+$7.65M

Sector Composition

Rank Sector Weight
1 Technology 30.92%
2 Financials 14.22%
3 Healthcare 10.78%
4 Industrials 10.11%
5 Communication Services 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$83.1B
$20.2M 0.88%
28,317
+54
+0.2% +$45.3K
IWD icon
52
iShares Russell 1000 Value ETF
IWD
$84.3B
$18M 0.78%
97,085
+86,571
+823% +$16.6M
CE icon
53
Celanese
CE
$5.05B
$10.1M 0.44%
145,715
+83
+0.1% +$7.98K
AVGO icon
54
Broadcom
AVGO
$2T
$9.19M 0.4%
39,635
+275
+0.7% +$50.9K
V icon
55
Visa
V
$678B
$5.88M 0.26%
18,591
+491
+3% +$148K
JNJ icon
56
Johnson & Johnson
JNJ
$631B
$4.13M 0.18%
28,591
-821
-3% -$127K
ABBV icon
57
AbbVie
ABBV
$440B
$3.91M 0.17%
21,989
-1,609
-7% -$296K
ACN icon
58
Accenture
ACN
$109B
$3.22M 0.14%
9,158
-459
-5% -$165K
CRM icon
59
Salesforce
CRM
$162B
$2.84M 0.12%
8,508
-730
-8% -$233K
ABT icon
60
Abbott
ABT
$190B
$2.73M 0.12%
24,096
-441
-2% -$51K
TMUS icon
61
T-Mobile US
TMUS
$192B
$2.51M 0.11%
11,392
-373
-3% -$84.8K
GILD icon
62
Gilead Sciences
GILD
$167B
$2.14M 0.09%
23,139
-1,343
-5% -$121K
AXP icon
63
American Express
AXP
$231B
$2.14M 0.09%
7,196
-193
-3% -$55.4K
BMY icon
64
Bristol-Myers Squibb
BMY
$132B
$2.1M 0.09%
37,096
-3,456
-9% -$193K
BKNG icon
65
Booking.com
BKNG
$160B
$2.06M 0.09%
10,375
T icon
66
AT&T
T
$166B
$1.91M 0.08%
83,697
-5,040
-6% -$113K
AMGN icon
67
Amgen
AMGN
$225B
$1.85M 0.08%
7,082
+227
+3% +$67.3K
PCAR icon
68
PACCAR
PCAR
$69.8B
$1.8M 0.08%
17,264
+1,464
+9% +$160K
CAT icon
69
Caterpillar
CAT
$396B
$1.79M 0.08%
4,942
-255
-5% -$98.9K
AON icon
70
Aon
AON
$75.6B
$1.78M 0.08%
4,955
+176
+4% +$64.7K
ORLY icon
71
O'Reilly Automotive
ORLY
$75.7B
$1.76M 0.08%
22,305
TXN icon
72
Texas Instruments
TXN
$260B
$1.76M 0.08%
9,399
+159
+2% +$31.8K
INTU icon
73
Intuit
INTU
$91.5B
$1.75M 0.08%
+2,782
New +$1.78M
MPC icon
74
Marathon Petroleum
MPC
$91.8B
$1.74M 0.08%
12,443
+110
+0.9% +$16.8K
QCOM icon
75
Qualcomm
QCOM
$172B
$1.7M 0.07%
11,057
+818
+8% +$134K

Similar funds

Applied Finance Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Applied Finance Capital Management held 335 positions worth $2.3B, down 1.7% from $2.34B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Applied Finance Capital Management's Q4 2024 filing shows 37 new, 65 increased, 82 reduced and 38 closed positions. Its largest new stake was CBRE Group: 361,683 shares worth $47.5M. The largest sale was Microchip Technology, an estimated $42.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

  • Applied Finance Capital Management's largest Q4 2024 buy was CBRE Group: 361,683 shares worth $47.5M.
  • Applied Finance Capital Management added most to Applied Materials in Q4 2024, an estimated $52.3M increase.
  • Applied Finance Capital Management's biggest Q4 2024 reduction was Microchip Technology, cutting an estimated $42.6M.
  • Applied Finance Capital Management fully exited Philip Morris in Q4 2024, selling an estimated $1.96M.
  • Applied Finance Capital Management's ten largest holdings make up 28% of its $2.3B portfolio in Q4 2024.
  • Applied Finance Capital Management opened 37 new positions and closed 38 in Q4 2024.
  • Applied Finance Capital Management's portfolio value fell 1.7% quarter-over-quarter to $2.3B.

Based on Applied Finance Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.